Tilray Brands (TLRY) stock

Cannabis and drinks , market cap $415M

Cannabis and drinks

Worth $415M

$2.65

-7.02%

As of Tuesday's close · Live for Pro members at the open

Why is TLRY down?

Down 7.0% today, more than its health care peers' 1.0%; no story names it yet.

Down

Down 40% in 3 months while the S&P 500 fell 2%.

Its Oct 8 results: cannabis net revenue was $56.1M, from $64.5M a year before; adjusted EBITDA was $9.2M, from $10.2M. It fell 3% on Oct 8.

Sources: Price history, Nov 9, 2026; Company release, Oct 8, 2026

−3Long-term trend below a falling 200-day average, down over one year, down over two years

Tell me next time TLRY moves

Free account, no card. An optional alert when TLRY moves or its score changes.

Or see it live, free until Thursday morning. No account.

1 more reason, free with an account →2 more reasons why TLRY is down, from its filings, with the other side and the timeline, for Pro members.

Quality Score

-6

Poor

In its industry

#83of 90

Pharma

Checks firing

0of 14

Trending down

From 52-week high

-83.1%

under its best in a year

TLRY's Quality Score fell 2 points on Tue, Nov 10, to -6. Trading picked back up (2 chart checks stopped).

See TLRY's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on TLRY

Key facts on TLRY
Since its Nov 2021 high	Down 98% while sales grew 88%
Latest filing	8-K, Oct 8 Reported its quarterly results

1 more reason behind TLRY's -6, free with an account →4 more reasons behind TLRY's -6, for Pro members.

TLRY in the news

TodayNo story names it yet.

What's next

Wed Nov 18: Annual meeting, online11:00 AM ET. Proxy filed Sep 28.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

TLRY catalysts

Coming up

After its last 4 reports it closed -2.2% on average, higher 1 of 4 times.

31 past catalysts since 2019, with sizes and sources, for Pro members.

How TLRY ranks in Pharma

TLRY is #83 of 90 by Quality Score.

How TLRY ranks in Pharma
Rank	Stock	Checks	Quality Score
1	ABBVAbbVie	10/14	23
2	LLYEli Lilly	8/14	21
3	PFEPfizer	6/14	17
	SVRASavara		Open for its score
	TKNOAlpha Teknova		Open for its score
	VSTMVerastem		Open for its score
	VTRSViatris		Open for its score
83	TLRYTilray Brands	0/14	-6

Net income over four quarters: TLRY -$164M, CRON $57.8M.

When does TLRY report earnings, and what happens after?

Expected to report Thu Jan 7, before the open (in 58 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What TLRY reported on Oct 8, 2026

The quarter

Sales of $257.1M.

The quarter that ended Aug 31, from the company's press release

The press release The filing on EDGAR

Where the sales came from

Where the quarter's sales came from
Line	Q1 FY27	Q1 FY26
By segment
Beverage Alcohol Businessup 78%	$104M37%	$58.5M28%

Each quarter's sales and their share of its total. Figures as filed (SEC filing, Oct 8)

7 more lines, for Pro members.

The outlook

No outlook figures read from this release.

The numbers

Market value: $415M; today
Sales: $963M; up 15.9% on the year

Sales grew 12% a year over 5 years, fiscal 2021 to 2026.

4 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on TLRY: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

-5.1%-1.0%-3.4%

Apr 1Jul 28Oct 8

Reported	When	Gap	Reaction	5 days
Oct 8, 2026Before open	Before open	-6.1%	-3.4%	-15.5%
Jul 28, 2026After close	After close	0.0%	-1.0%	+15.1%
Apr 1, 2026Before open	Before open	+2.2%	-5.1%	+4.3%

TLRY closed higher after 1 of its last 4 reports.

All 4 reports, and TLRY's Quality Score going into each

TLRY sales and profit by year

Sales and profit by year

Sales grew in six of the last seven years, to $915M in 2026. It lost money in each of the eight years.

Nothing is firing on TLRY right now

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on TLRY, and all 14 on every stock.Get in free →

TLRY RSI today: 35.8, below its 50-day and 200-day averages

Not scored

RSI 35.8, MACD above signal, below both averages. Not scored.13 readings

The deep dive on TLRY

What it does and how it makes money4 findingsAn operating loss of $63.0M in fiscal 2026, on $915M of sales.Annual report, filed Jul 28, 2026
Where it stands5 findingsFor Pro members5 findings on where TLRY stands: its cash, debt, and share count, for Pro members
What changed in its filings2 findings"On December 31, 2025, MMIRF, LLC filed a complaint in the Superior Court of California …" (10-K for fiscal 2026)SEC filing · Jul 28, 2026
Who holds and trades it3 findingsFor Pro members3 findings on who holds and trades TLRY, for Pro members
Against its closest peers1 peerNet income over four quarters: TLRY -$164M, CRON $57.8M.

12 more findings on TLRY, each with its source, for Pro members.

TLRY share count over time

Shares: 25.8% more than a year ago (to Aug 31).

Shares of TLRY outstanding, as filed
Shares outstanding	As of
147.8M	Oct 6, 2026
136.2M	Jul 24, 2026
116.5M	Mar 30, 2026
116.5M	Jan 6, 2026

Offerings, shelves, and splits of TLRY, from its filings
From its filings	Filed
Set up an at-the-market program for up to $180M of shares, about 43% of its market value	Apr 15, 2026
Priced a sale of shares	Sep 10, 2025

TLRY insider trades

3 insiders bought $69K across 3 filings in the last 6 months. No open-⁠market sales on record. The newest:

BuyMitchell Gendel$11KGlobal General Counselat $4.43 on Aug 6, filed Aug 7

BuyMitchell GendelGlobal General Counsel$11Kat $4.43 on Aug 6, filed Aug 7

All 3 insider filings on TLRY from the last six months, for Pro members.

All TLRY insider trades

TLRY's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Irwin D. SimonPresident and CEO · no trades on file
Carl A. MertonChief Financial Officer · 1 trade
Denise M. FaltischekChief Strategy Officer · 1 trade
Mitchell GendelGlobal General Counsel · 1 trade
David G. HopkinsonDirector · 1 trade
David F. ClanachanDirector · no trades on file
Johann Michael HerhaltDirector · no trades on file
Renah PersofskyDirector · no trades on file

2 more officers and directors file at TLRY.

See insider trades by person

About Tilray Brands

Tilray is a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.

3,595 employeesNew York, NYtilray.com

What Tilray Brands says it competes with

“We continue to face intense competition from the illicit market as well as other companies, some of which may have longer operating histories and more financial resources and manufacturing and marketing experience.”

From its annual report, SEC filing · Jul 28, 2026

Here is what Pro members see.

The same page for Pro members, on Microsoft
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on TLRY and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

What would turn TLRY's score around: 9 things
4 more filings explained, a plain line each
4 more things pulling TLRY's score down

BreakawayAug 7Mitchell Gendel bought TLRY$11K at $4.43, filed Aug 7

Alerts are optional.

See TLRY's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: TLRY's Quality Score is -6 (Poor), #83 of 90 in Pharma. Insiders bought $69K in the last 6 months (Form 4).

What does TLRY's Quality Score say?

TLRY scores -6 today, which Breakaway calls Poor. It is #83 of 90 in Pharma by Quality Score, with 0 of 14 chart checks firing. Down 40% in 3 months while the S&P 500 fell 2%. Shares: 25.8% more than a year ago (to Aug 31). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is TLRY's Quality Score?

TLRY scores -6 today, which Breakaway calls Poor (below zero). That is #83 of 90 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind TLRY's -6.

Are insiders buying TLRY?

3 insiders bought $69K across 3 filings in the last 6 months. No open-⁠market sales on record. The newest is Mitchell Gendel, Global General Counsel, who bought $11K on Aug 6. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.